BMJ Open Diabetes Research & Care

Scope & Guideline

Advancing diabetes care through innovative research.

Introduction

Immerse yourself in the scholarly insights of BMJ Open Diabetes Research & Care with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationBMJ OPEN DIAB RES CA / BMJ Open Diab. Res. Care
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

BMJ Open Diabetes Research & Care focuses on advancing the understanding, prevention, and management of diabetes and its complications through high-quality research. The journal emphasizes interdisciplinary approaches and aims to bridge the gap between clinical practice and research.
  1. Diabetes Epidemiology and Public Health:
    The journal publishes studies examining the epidemiology of diabetes, including prevalence, incidence, and risk factors across different populations, with a focus on public health implications and interventions.
  2. Clinical Management and Treatment Strategies:
    Research on various treatment modalities, including pharmacological and non-pharmacological interventions for diabetes management, is a core focus. This includes studies on the efficacy and safety of new diabetes medications and technologies.
  3. Complications of Diabetes:
    BMJ Open Diabetes Research & Care explores the various complications associated with diabetes, such as cardiovascular disease, nephropathy, retinopathy, and neuropathy, and their impact on patient outcomes.
  4. Health Disparities and Social Determinants of Health:
    The journal emphasizes research addressing health disparities in diabetes care and outcomes, focusing on socioeconomic, ethnic, and geographic factors that influence diabetes management and health equity.
  5. Innovative Research Methodologies:
    The use of advanced research methodologies, including machine learning, big data analytics, and system dynamics modeling, to improve diabetes care and outcomes is highlighted.
  6. Patient-Centered Research:
    Studies focusing on patient-reported outcomes, self-management, and the psychosocial aspects of living with diabetes are significant, aiming to enhance patient engagement and quality of care.
Recent publications in BMJ Open Diabetes Research & Care reflect emerging trends and themes that are gaining traction in diabetes research. These areas highlight the evolving landscape of diabetes care, incorporating new technologies, interdisciplinary approaches, and a greater emphasis on health equity.
  1. Digital Health and Telemedicine:
    The integration of digital health technologies, including telemedicine and remote monitoring tools, into diabetes care is increasingly prominent, especially in the context of the COVID-19 pandemic's impact on healthcare delivery.
  2. Precision Medicine and Personalization:
    Research focusing on precision medicine approaches tailored to individual patient profiles, including genetic, metabolic, and lifestyle factors, is on the rise, reflecting a shift towards more personalized diabetes management.
  3. Diabetes and Mental Health:
    There is growing recognition of the interplay between diabetes and mental health, with studies exploring the psychological aspects of living with diabetes, including stress, depression, and the impact on glycemic control.
  4. Environmental and Socioeconomic Influences:
    Research examining the impact of environmental factors and socioeconomic status on diabetes prevalence, management, and outcomes is increasingly relevant, highlighting the importance of social determinants of health.
  5. Machine Learning and Data Analytics:
    The application of machine learning and data analytics in diabetes research is emerging as a key trend, offering insights into risk prediction, disease progression, and treatment optimization.

Declining or Waning

While BMJ Open Diabetes Research & Care continues to cover a wide range of diabetes-related topics, certain areas of research have seen a decrease in publication frequency or relevance. These waning themes may indicate shifting priorities within the field or a saturation of research in those areas.
  1. Traditional Dietary Interventions:
    Research focusing solely on traditional dietary interventions for diabetes management has declined, as newer studies explore more complex interactions involving microbiota, metabolic pathways, and personalized nutrition.
  2. Basic Science and Preclinical Studies:
    There has been a noticeable reduction in the publication of basic science and preclinical studies, with a shift towards more applied clinical research and real-world evidence that directly informs diabetes care.
  3. Single-Factor Studies:
    Research examining the effects of single factors (e.g., one specific medication or lifestyle change) on diabetes outcomes has decreased, as there is a growing emphasis on multifactorial approaches and comprehensive care models.

Similar Journals

Journal of Endocrinology Metabolism and Diabetes of South Africa

Advancing knowledge in endocrinology and metabolism.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1608-9677Frequency: 3 issues/year

Journal of Endocrinology Metabolism and Diabetes of South Africa, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital platform for advancing research and knowledge dissemination in the fields of endocrinology, metabolism, and diabetes. Since its transition to Open Access in 2012, it has enabled greater accessibility to crucial findings and data, broadening its reach to researchers, practitioners, and students alike. Though its coverage in Scopus was discontinued in 2018, the journal continues to play an important role in fostering discourse in the medical community, as evidenced by its ranking within the 19th and 16th percentiles for Internal Medicine and Endocrinology, diabetes and metabolism, respectively. With its commitment to addressing pressing health issues in South Africa and beyond, this journal remains an invaluable resource for those seeking to understand and tackle the complexities of metabolic diseases.

DIABETES & METABOLISM

Advancing the Science of Diabetes and Metabolism
Publisher: MASSON EDITEURISSN: 1262-3636Frequency: 6 issues/year

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.

JOURNAL OF DIABETES AND ITS COMPLICATIONS

Unraveling the challenges of diabetes, one study at a time.
Publisher: ELSEVIER SCIENCE INCISSN: 1056-8727Frequency: 6 issues/year

JOURNAL OF DIABETES AND ITS COMPLICATIONS is a distinguished peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the knowledge and management of diabetes and its multifaceted complications. With an ISSN of 1056-8727 and E-ISSN 1873-460X, this journal has established its significance in the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine, as reflected in its Q2 and Q1 quartile rankings for 2023, and its commendable Scopus rankings. The journal, which has been converging knowledge since 1992 and continues to publish vital research until 2024, serves as a platform for researchers, professionals, and students aiming to delve deeper into the mechanisms, treatment, and implications of diabetes and its related disorders. While access is not open, the journal remains a critical resource for those invested in understanding and combating the challenges posed by diabetes, ultimately contributing to better health outcomes.

DIABETIC MEDICINE

Advancing diabetes research for a healthier tomorrow.
Publisher: WILEYISSN: 0742-3071Frequency: 12 issues/year

DIABETIC MEDICINE is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of endocrinology, specifically focusing on the pathophysiology, management, and prevention of diabetes mellitus and its complications. With an impressive impact factor reflecting its significant role in shaping clinical practice and research, DIABETIC MEDICINE holds a prominent position among its peers, categorized in the Q1 quartiles for Endocrinology, Diabetes and Metabolism, and Internal Medicine. Since its inception in 1984, the journal has provided a platform for rigorous and innovative research, fostering collaborative efforts among researchers, clinicians, and students to enhance diabetes care. The journal is esteemed for its high-ranking performance in Scopus, highlighted by its ranking of #33 in Internal Medicine and #64 in Endocrinology, Diabetes, and Metabolism. By offering insightful access to groundbreaking studies and reviews, DIABETIC MEDICINE plays a crucial role in informing policy and improving medical outcomes for individuals with diabetes, making it an essential resource for those in medical and clinical research fields.

British Journal of Diabetes

Empowering healthcare professionals with cutting-edge insights.
Publisher: ASSOC BRITISH CLINICAL DIABETOLOGISTSISSN: 2397-6233Frequency: 2 issues/year

The British Journal of Diabetes, published by the Association of British Clinical Diabetologists, is a premier journal dedicated to advancing the understanding, prevention, and management of diabetes. With an ISSN of 2397-6233, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that address the complexities of diabetes care and research. While currently not available as an open access option, the journal is committed to enhancing the visibility of cutting-edge diabetes research for healthcare professionals and academics. Located in the heart of England, this journal plays a crucial role in bridging the gap between clinical practice and research innovation, making it an essential resource for practitioners, researchers, and students alike. The British Journal of Diabetes is determined to contribute significantly to the global dialogue on diabetes, as it covers a wide spectrum of topics from epidemiology and public health to novel therapeutic strategies and patient management approaches.

ACTA DIABETOLOGICA

Fostering Breakthroughs in Metabolic Health
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0940-5429Frequency: 12 issues/year

ACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.

Journal of Diabetology

Bridging research and practice in diabetes management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2543-3288Frequency: 3 issues/year

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

Science of Diabetes Self-Management and Care

Transforming Diabetes Management with Cutting-Edge Insights
Publisher: SAGE PUBLICATIONS INCISSN: 2635-0106Frequency: 6 issues/year

Science of Diabetes Self-Management and Care is an esteemed journal published by SAGE Publications Inc, dedicated to advancing research and knowledge in the fields of endocrinology, diabetes management, and health professions. Established in 2021, this peer-reviewed, open-access journal aims to provide a platform for the dissemination of innovative and practical strategies for diabetes self-management and care, meeting the needs of an increasingly diverse patient population. With an impressive impact factor reflective of its quality and relevance, the journal has achieved notable rankings—Q2 in Endocrinology, Diabetes and Metabolism, and Q1 in Health Professions and Social Sciences, underscoring its significance in both clinical practice and healthcare research. Researchers, healthcare professionals, and students will find valuable insights and breakthroughs in diabetes care, making this journal an essential resource for those seeking to contribute to the future of diabetes self-management."

CURRENT DIABETES REVIEWS

Unveiling the Latest in Diabetes Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3998Frequency: 9 issues/year

CURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.

Diabetes & Metabolism Journal

Transforming diabetes research into actionable insights.
Publisher: KOREAN DIABETES ASSOCISSN: 2233-6079Frequency: 6 issues/year

Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.